Blood proteins may identify vulnerability of pancreatic cancers to avastin
Tuesday, June 7, 2011 - 08:01
in Health & Medicine
(Medical Xpress) -- Tiny tumor proteins circulating in blood may be used to identify which pancreatic cancer patients would benefit from the drug Avastin, researchers at Duke University Medical Center have found.